How should I initiate a furosemide (frusemide) infusion, including preparation, dosing, and monitoring, in a patient who is not anuric, has a systolic blood pressure ≥ 90 mm Hg, eGFR ≥ 30 mL/min/1.73 m², and acceptable electrolyte levels?

How to Start Furosemide Infusion

Begin with a 20-40 mg IV bolus of furosemide, then initiate continuous infusion at 3-5 mg/hour, titrating upward every 2-3 days based on urine output and clinical response, with a maximum rate of 24 mg/hour. 1

Initial Preparation and Dosing

Starting Dose Selection

• For diuretic-naive patients or those not on chronic diuretics: Start with 20-40 mg IV bolus followed by 3 mg/hour continuous infusion 12
• For patients already on oral diuretics: Use at least the equivalent of their oral dose as the initial IV bolus, then begin infusion 3
• For acute pulmonary edema: Begin with 40 mg IV bolus; if inadequate response in 1 hour, increase to 80 mg 2

Infusion Preparation

Critical preparation steps 2:

• Add furosemide to Normal Saline, Lactated Ringer's, or D5W only after adjusting pH above 5.5
• The solution pH must remain weakly alkaline to neutral (furosemide precipitates at pH <7)
• Never mix with acidic medications (labetalol, ciprofloxacin, amrinone, milrinone) in the same line
• Administer at a rate not exceeding 4 mg/min 2

Dose Titration Algorithm

Follow this stepwise escalation 1:

1. Initial phase: Start at 3 mg/hour (or 20 mg bolus equivalent)
2. Reassess at 1-4 hours: Monitor urine output, symptoms, weight
3. If inadequate response: Double the dose every 2-3 days until goal achieved
4. Maximum infusion rate: 24 mg/hour (do not exceed 620 mg/day total) 1
5. Alternative bolus strategy: Can use 2-3 times daily boluses instead, starting at 20-40 mg and doubling as needed up to 160-200 mg per dose 42

When to Withhold or Stop

Do not initiate or continue if 1:

• Patient is anuric or dialysis-dependent
• Serum creatinine >3 mg/dL with oliguria
• Within 12 hours of last fluid bolus or vasopressor administration
• Systolic blood pressure <90 mmHg with symptomatic hypotension 53

Monitoring Requirements

Immediate Monitoring (First 24-48 Hours)

• Urine output: Place bladder catheter to accurately measure hourly output 5
• Daily weights: Target 0.5-1.0 kg daily loss 6
• Blood pressure: Frequent monitoring; consider arterial line if using high doses 3
• Electrolytes and renal function: Check daily initially 77

Ongoing Surveillance

Check within 1-3 days of any dose escalation 77:

• Serum potassium and magnesium (risk of depletion and arrhythmias)
• Serum creatinine and eGFR
• Serum sodium (especially if >240 mg/day furosemide)
• Volume status assessment

Continuous Infusion vs. Bolus Dosing

Continuous infusion is superior to repeated boluses for diuretic-resistant patients 777. The evidence shows:

• Greater total diuresis: 12-26% increase in urine output 8
• Enhanced natriuresis: 11-33% increase in sodium excretion 89
• At least as safe as bolus dosing 77
• More predictable response: Maintains steady drug levels 1011

However, one practical limitation: many hospitals require continuous infusions be given in intermediate or intensive care settings 77.

Strategies for Diuretic Resistance

If inadequate response despite furosemide infusion up to 10-20 mg/hour 7:

Sequential Nephron Blockade Options

1. Add thiazide diuretic (Class IIa, Level B) 7:

   • Metolazone 2.5-5 mg PO once daily
   • Hydrochlorothiazide 25-100 mg PO
   • Warning: Significantly increases risk of hypokalemia, hypomagnesemia, and acute kidney injury 12

2. Add acetazolamide 500 mg IV 13:

   • Useful in contraction alkalosis
   • Safer electrolyte profile than thiazides
   • Coordinate with nephrology

3. Consider SGLT2 inhibitors (emerging evidence):

   • Favorable renal and electrolyte safety profile 12
   • May enhance diuresis without increased AKI risk

Alternative Approaches

• Increase infusion rate: Up to maximum 24 mg/hour 1
• Switch loop diuretics: Consider bumetanide (better oral bioavailability) or torsemide 6
• Ultrafiltration: For severe renal insufficiency with stable (not acute) renal function, in consultation with nephrology 77

Common Pitfalls and How to Avoid Them

Electrolyte Depletion

• Risk amplified when combining diuretics 64
• Concomitant ACE inhibitor/ARB + spironolactone usually prevents potassium loss (avoid additional K+ supplements) 4
• Check magnesium if arrhythmias develop

Volume Depletion vs. Worsening Heart Failure

Critical distinction 77:

• If hypotension/azotemia WITHOUT fluid retention signs: Reduce diuretic (volume depletion)
• If hypotension/azotemia WITH persistent congestion: This reflects worsening HF and declining perfusion—do not reduce diuretics; consider advanced therapies

Renal Function Changes

• Mild creatinine fluctuations (<30% from baseline): Observe only 77
• Oliguria or >30% creatinine increase: Prompt action required 7
• Paradoxical improvement: In severe volume overload, diuresis may actually improve renal function by optimizing cardiac output 77

Drug Interactions

• NSAIDs: Significantly impair diuretic response 77
• Acidic medications: Will precipitate furosemide in IV line 2

Special Populations

Preserved vs. Reduced Ejection Fraction

• No difference in efficacy or safety between HFpEF and HFrEF 11
• Same dosing approach applies

Severe Renal Dysfunction (eGFR ≤30 mL/min/1.73m²)

• Neither metolazone nor acetazolamide provides additional benefit at this level 14
• Consider ultrafiltration if refractory 7
• Higher baseline doses needed but response is blunted 14

ARDS Patients (Non-Shock)

Use conservative fluid strategy with specific targets 1:

• CVP >8 or PAOP >12 with urine output <0.5 mL/kg/h: Give furosemide
• Start 20 mg bolus or 3 mg/hour infusion
• Withhold if on vasopressors within 12 hours

Transition to Oral Therapy

Replace with oral therapy as soon as practical 152:

• IV furosemide is approximately twice as potent as oral 13
• Bumetanide has 1:1 oral-to-IV equivalence 13
• Torsemide (oral only in US) has longer duration of action (12-16 hours) 6